Kiniksa Pharmaceuticals International Plc (KNSA)
77.09
-0.82
(-1.05%)
USD |
NASDAQ |
Sep 08, 16:00
80.00
+2.91
(+3.77%)
After-Hours: 20:00
Kiniksa Pharmaceuticals International Total Liabilities (Quarterly) : 241.96M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 241.96M |
| March 31, 2026 | 219.59M |
| December 31, 2025 | 196.03M |
| September 30, 2025 | 176.95M |
| June 30, 2025 | 166.14M |
| March 31, 2025 | 141.84M |
| December 31, 2024 | 142.12M |
| September 30, 2024 | 118.29M |
| June 30, 2024 | 107.33M |
| March 31, 2024 | 87.78M |
| December 31, 2023 | 87.48M |
| September 30, 2023 | 77.94M |
| June 30, 2023 | 72.68M |
| March 31, 2023 | 52.77M |
| December 31, 2022 | 63.52M |
| September 30, 2022 | 75.94M |
| June 30, 2022 | 57.08M |
| March 31, 2022 | 64.72M |
| Date | Value |
|---|---|
| December 31, 2021 | 47.76M |
| September 30, 2021 | 38.81M |
| June 30, 2021 | 43.42M |
| March 31, 2021 | 40.46M |
| December 31, 2020 | 37.53M |
| September 30, 2020 | 25.90M |
| June 30, 2020 | 21.02M |
| March 31, 2020 | 20.27M |
| December 31, 2019 | 29.11M |
| September 30, 2019 | 29.89M |
| June 30, 2019 | 32.94M |
| March 31, 2019 | 39.64M |
| December 31, 2018 | 42.70M |
| September 30, 2018 | 28.19M |
| June 30, 2018 | 23.33M |
| March 31, 2018 | 19.30M |
| December 31, 2017 | 17.43M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Autolus Therapeutics Plc | 418.39M |
| Barinthus Biotherapeutics Plc | 24.76M |
| Scancell Holdings Plc | -- |
| OptiBiotix Health Plc | -- |
| Immunocore Holdings Plc | 699.62M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 896.11M |
| Shareholders Equity (Quarterly) | 654.15M |
| Debt to Equity Ratio | 0.0136 |
| Current Ratio | 3.904 |
| Net Debt Paydown Yield | 0.00% |